Graphic: megaphone with text saying Raise your voice for people with MS # Speak up for MS

Ask your MP to speak up for ocrelizumab for progressive MS

Earlier this year the National Institute for Health and Care Excellence (NICE) rejected the first disease modifying treatment (DMT) for progressive MS because they say it costs too much.

DMTs are not a cure for MS, but they can slow down damage that builds up over time. There are several DMTs for relapsing MS. But ocrelizumab (drug name Ocrevus) is the first and only one licensed to treat primary progressive MS.

NICE approved ocrelizumab for relapsing MS, but rejected it for early primary progressive MS and we don't think that's fair.

Tweet your MP to show up for ocrelizumab

Speak up for treatment for progressive MS in Westminster

In September this year, over 21,000 of us spoke up together to call for NICE, NHS England and the drug manufacturer Roche to find a deal together.

Now we need support from Westminster to help keep up the pressure.

We've organised an event in the Houses of Parliament on Monday 26 November. It's 2-4pm in the Jubilee Room and we need all our MPs to attend and speak up for ocrelizumab for progressive MS.

Tweet your MP to show up for ocrelizumab

Not on Twitter? Email your MP to show up for ocrelizumab

What's the research?

In medical trials, people with primary progressive MS who took ocrelizumab had 25% less risk of their disability getting worse.

Read more about ocrelizumab research

So why did NICE say no?

NICE say the drug costs too much for the benefits it can provide. The drug company Roche offered a lower price for its use for progressive MS. But NICE say unless they get special approval from NHS England they can't buy it at two different prices for the different types of MS.

21,000 spoke up, now MPs must help

We’re calling for the manufacturer Roche, NICE and NHS England to put patients first and agree a deal to make ocrelizumab available at a price the NHS can afford.

Right now, this decision affects England and Wales. But getting the right deal is crucial to make sure ocrelizumab can go through approval processes in the other nations in the UK without unnecessary delays.

Tweet your MP to show up for ocrelizumab

Or if you're not on twitter, email them to ask for their support.

The next research breakthrough is in reach

Your donation will help stop MS.

  • Please enter an amount

    Our minimum donation is £2, please enter a different amount.

£10could buy vital lab supplies for MS researchers, helping them find ways to stop MS faster

£20could pay for lab equipment like petri dishes to grow bacteria important for studying the genetics of MS

£30could process one blood sample, giving us crucial information about genes that could lead to treatment breakthroughs

Every penny you give really does take us a step closer to stopping MS. Your donation will make a difference.

  • Please enter an amount

    Our minimum donation is £2, please enter a different amount.

£10a month could pay for lab equipment like microscope slides to study the building blocks of MS

£20a month could pay for lab equipment like petri dishes to grow bacteria important for studying genetics

£30a month could process a blood sample to help us understand what causes MS, so we can stop it in its tracks

Your regular donation means we can keep funding world class MS research with confidence. Together we will stop MS.

Photo: young girl with MS sits in hospital chair smiling at male nurse